Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells
Standard
Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells. / Horst, Andrea Kristina; Neumann, Katrin; Diehl, Linda; Tiegs, Gisa.
in: CELL MOL IMMUNOL, Jahrgang 13, Nr. 3, 04.04.2016, S. 277-292.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells
AU - Horst, Andrea Kristina
AU - Neumann, Katrin
AU - Diehl, Linda
AU - Tiegs, Gisa
PY - 2016/4/4
Y1 - 2016/4/4
N2 - The liver is a tolerogenic organ with exquisite mechanisms of immune regulation that ensure upkeep of local and systemic immune tolerance to self and foreign antigens, but that is also able to mount effective immune responses against pathogens. The immune privilege of liver allografts was recognized first in pigs in spite of major histo-compatibility complex mismatch, and termed the "liver tolerance effect". Furthermore, liver transplants are spontaneously accepted with only low-dose immunosuppression, and induce tolerance for non-hepatic co-transplanted allografts of the same donor. Although this immunotolerogenic environment is favorable in the setting of organ transplantation, it is detrimental in chronic infectious liver diseases like hepatitis B or C, malaria, schistosomiasis or tumorigenesis, leading to pathogen persistence and weak anti-tumor effects. The liver is a primary site of T-cell activation, but it elicits poor or incomplete activation of T cells, leading to their abortive activation, exhaustion, suppression of their effector function and early death. This is exploited by pathogens and can impair pathogen control and clearance or allow tumor growth. Hepatic priming of T cells is mediated by a number of local conventional and nonconventional antigen-presenting cells (APCs), which promote tolerance by immune deviation, induction of T-cell anergy or apoptosis, and generating and expanding regulatory T cells. This review will focus on the communication between classical and nonclassical APCs and lymphocytes in the liver in tolerance induction and will discuss recent insights into the role of innate lymphocytes in this process.Cellular & Molecular Immunology advance online publication, 4 April 2016; doi:10.1038/cmi.2015.112.
AB - The liver is a tolerogenic organ with exquisite mechanisms of immune regulation that ensure upkeep of local and systemic immune tolerance to self and foreign antigens, but that is also able to mount effective immune responses against pathogens. The immune privilege of liver allografts was recognized first in pigs in spite of major histo-compatibility complex mismatch, and termed the "liver tolerance effect". Furthermore, liver transplants are spontaneously accepted with only low-dose immunosuppression, and induce tolerance for non-hepatic co-transplanted allografts of the same donor. Although this immunotolerogenic environment is favorable in the setting of organ transplantation, it is detrimental in chronic infectious liver diseases like hepatitis B or C, malaria, schistosomiasis or tumorigenesis, leading to pathogen persistence and weak anti-tumor effects. The liver is a primary site of T-cell activation, but it elicits poor or incomplete activation of T cells, leading to their abortive activation, exhaustion, suppression of their effector function and early death. This is exploited by pathogens and can impair pathogen control and clearance or allow tumor growth. Hepatic priming of T cells is mediated by a number of local conventional and nonconventional antigen-presenting cells (APCs), which promote tolerance by immune deviation, induction of T-cell anergy or apoptosis, and generating and expanding regulatory T cells. This review will focus on the communication between classical and nonclassical APCs and lymphocytes in the liver in tolerance induction and will discuss recent insights into the role of innate lymphocytes in this process.Cellular & Molecular Immunology advance online publication, 4 April 2016; doi:10.1038/cmi.2015.112.
U2 - 10.1038/cmi.2015.112
DO - 10.1038/cmi.2015.112
M3 - SCORING: Journal article
C2 - 27041638
VL - 13
SP - 277
EP - 292
JO - CELL MOL IMMUNOL
JF - CELL MOL IMMUNOL
SN - 1672-7681
IS - 3
ER -